Daxor Corporation (DXR)
USD 7.34
(-1.08%)
USD 7.34
(-1.08%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 755.65 Thousand USD | -38.52% |
| 2022 | 1.22 Million USD | -46.83% |
| 2021 | 2.31 Million USD | 617.06% |
| 2020 | -447.11 Thousand USD | -133.3% |
| 2019 | 1.34 Million USD | -69.86% |
| 2018 | 4.45 Million USD | 37.26% |
| 2017 | 3.24 Million USD | 425.25% |
| 2016 | 617.86 Thousand USD | -55.53% |
| 2015 | 1.38 Million USD | -93.49% |
| 2014 | 21.35 Million USD | 5.49% |
| 2013 | 20.24 Million USD | 0.0% |
| 2012 | - USD | -100.0% |
| 2011 | 13.99 Million USD | -48.8% |
| 2010 | 27.33 Million USD | 151.12% |
| 2009 | 10.88 Million USD | -0.49% |
| 2008 | 10.93 Million USD | 524.16% |
| 2007 | 1.75 Million USD | 172.01% |
| 2006 | 644.23 Thousand USD | -90.78% |
| 2005 | 6.99 Million USD | 70.16% |
| 2004 | 4.1 Million USD | 64.41% |
| 2003 | 2.49 Million USD | 75.85% |
| 2002 | 1.42 Million USD | 150.16% |
| 2001 | 568.05 Thousand USD | -67.67% |
| 2000 | 1.75 Million USD | -26.06% |
| 1999 | 2.37 Million USD | 18.8% |
| 1998 | 2 Million USD | -16.67% |
| 1997 | 2.4 Million USD | 60.0% |
| 1996 | 1.5 Million USD | -6.25% |
| 1995 | 1.6 Million USD | -57.89% |
| 1994 | 3.8 Million USD | -9.52% |
| 1993 | 4.2 Million USD | -55.79% |
| 1992 | 9.5 Million USD | 5.56% |
| 1991 | 9 Million USD | 63.64% |
| 1990 | 5.5 Million USD | 131.79% |
| 1989 | -17.3 Million USD | 3.89% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 1.64 Million USD | 0.0% |
| 2024 Q1 | 1.64 Million USD | 118.31% |
| 2023 Q3 | 755.65 Thousand USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2023 Q1 | - USD | -100.0% |
| 2023 Q4 | 755.65 Thousand USD | 0.0% |
| 2023 FY | 755.65 Thousand USD | -38.52% |
| 2022 FY | 1.22 Million USD | -46.83% |
| 2022 Q2 | 2.79 Million USD | 0.0% |
| 2022 Q4 | 1.22 Million USD | 0.0% |
| 2022 Q3 | 1.22 Million USD | -56.07% |
| 2022 Q1 | 2.79 Million USD | 21.04% |
| 2021 Q1 | 2.14 Million USD | 580.42% |
| 2021 FY | 2.31 Million USD | 617.06% |
| 2021 Q2 | 887.05 Thousand USD | -58.7% |
| 2021 Q3 | 3.73 Million USD | 321.44% |
| 2021 Q4 | 2.31 Million USD | -38.16% |
| 2020 Q3 | 797.68 Thousand USD | 142.09% |
| 2020 FY | -447.11 Thousand USD | -133.3% |
| 2020 Q4 | -447.11 Thousand USD | -156.05% |
| 2020 Q1 | 3.72 Million USD | 177.55% |
| 2020 Q2 | -1.89 Million USD | -150.86% |
| 2019 Q3 | 1.34 Million USD | -69.47% |
| 2019 FY | 1.34 Million USD | -69.86% |
| 2019 Q1 | 4.39 Million USD | -1.29% |
| 2019 Q2 | 4.39 Million USD | 0.0% |
| 2019 Q4 | 1.34 Million USD | 0.0% |
| 2018 Q1 | 4.36 Million USD | 0.65% |
| 2018 FY | 4.45 Million USD | 37.26% |
| 2018 Q4 | 4.45 Million USD | 0.0% |
| 2018 Q3 | 4.45 Million USD | 2.11% |
| 2018 Q2 | 4.36 Million USD | 0.0% |
| 2017 Q1 | 5.96 Million USD | 865.02% |
| 2017 Q2 | 4.06 Million USD | -31.76% |
| 2017 Q3 | 5.42 Million USD | 33.43% |
| 2017 Q4 | 4.33 Million USD | -20.16% |
| 2017 FY | 3.24 Million USD | 425.25% |
| 2016 Q3 | 4.98 Million USD | 1644.72% |
| 2016 Q4 | 617.86 Thousand USD | -87.61% |
| 2016 Q1 | 4.67 Million USD | 236.57% |
| 2016 Q2 | -322.75 Thousand USD | -106.9% |
| 2016 FY | 617.86 Thousand USD | -55.53% |
| 2015 Q3 | 6.29 Million USD | 40.68% |
| 2015 Q2 | 4.47 Million USD | -60.72% |
| 2015 Q1 | 11.38 Million USD | -46.68% |
| 2015 Q4 | 1.38 Million USD | -77.92% |
| 2015 FY | 1.38 Million USD | -93.49% |
| 2014 Q1 | 17.17 Million USD | -15.16% |
| 2014 Q2 | 17.17 Million USD | 0.0% |
| 2014 FY | 21.35 Million USD | 5.49% |
| 2014 Q3 | 21.35 Million USD | 24.33% |
| 2014 Q4 | 21.35 Million USD | 0.0% |
| 2013 Q3 | 20.24 Million USD | 12.56% |
| 2013 Q2 | 17.98 Million USD | 0.0% |
| 2013 FY | 20.24 Million USD | 0.0% |
| 2013 Q1 | 17.98 Million USD | 0.0% |
| 2013 Q4 | 20.24 Million USD | 0.0% |
| 2012 FY | - USD | -100.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2011 Q3 | 8.12 Million USD | -78.52% |
| 2011 FY | 13.99 Million USD | -48.8% |
| 2011 Q4 | 13.99 Million USD | 72.16% |
| 2011 Q1 | 33.67 Million USD | 23.19% |
| 2011 Q2 | 37.84 Million USD | 12.4% |
| 2010 FY | 27.33 Million USD | 151.12% |
| 2010 Q3 | 19.52 Million USD | 1.78% |
| 2010 Q2 | 19.18 Million USD | -21.75% |
| 2010 Q1 | 24.51 Million USD | 125.19% |
| 2010 Q4 | 27.33 Million USD | 40.01% |
| 2009 Q2 | 15.92 Million USD | -14.67% |
| 2009 FY | 10.88 Million USD | -0.49% |
| 2009 Q1 | 18.66 Million USD | 70.64% |
| 2009 Q3 | 11.93 Million USD | -25.04% |
| 2009 Q4 | 10.88 Million USD | -8.82% |
| 2008 FY | 10.93 Million USD | 524.16% |
| 2008 Q4 | 10.93 Million USD | 921.38% |
| 2008 Q3 | -1.33 Million USD | -209.05% |
| 2008 Q2 | 1.22 Million USD | -37.09% |
| 2008 Q1 | 1.94 Million USD | 10.77% |
| 2007 Q2 | 3.7 Million USD | -70.72% |
| 2007 Q3 | 589.21 Thousand USD | -84.12% |
| 2007 Q4 | 1.75 Million USD | 197.41% |
| 2007 FY | 1.75 Million USD | 172.01% |
| 2007 Q1 | 12.66 Million USD | 1866.16% |
| 2006 FY | 644.23 Thousand USD | -90.78% |
| 2006 Q2 | 5.59 Million USD | -3.81% |
| 2006 Q1 | 5.81 Million USD | -16.86% |
| 2006 Q3 | 4.12 Million USD | -26.14% |
| 2006 Q4 | 644.23 Thousand USD | -84.4% |
| 2005 Q4 | 6.99 Million USD | 24.96% |
| 2005 Q2 | 6.54 Million USD | 49.29% |
| 2005 Q1 | 4.38 Million USD | 6.68% |
| 2005 FY | 6.99 Million USD | 70.16% |
| 2005 Q3 | 5.59 Million USD | -14.5% |
| 2004 Q4 | 4.1 Million USD | -5.13% |
| 2004 Q3 | 4.33 Million USD | 7.72% |
| 2004 FY | 4.1 Million USD | 64.41% |
| 2004 Q1 | 2.8 Million USD | 12.36% |
| 2004 Q2 | 4.01 Million USD | 43.17% |
| 2003 Q2 | 2.57 Million USD | 36.48% |
| 2003 FY | 2.49 Million USD | 75.85% |
| 2003 Q4 | 2.49 Million USD | -5.93% |
| 2003 Q3 | 2.65 Million USD | 3.24% |
| 2003 Q1 | 1.88 Million USD | 32.66% |
| 2002 Q2 | 342.78 Thousand USD | -18.12% |
| 2002 Q1 | 418.63 Thousand USD | -26.3% |
| 2002 Q3 | 887.97 Thousand USD | 159.05% |
| 2002 Q4 | 1.42 Million USD | 60.03% |
| 2002 FY | 1.42 Million USD | 150.16% |
| 2001 Q3 | 1.91 Million USD | -1.48% |
| 2001 Q2 | 1.94 Million USD | 6.16% |
| 2001 Q1 | 1.82 Million USD | 4.09% |
| 2001 FY | 568.05 Thousand USD | -67.67% |
| 2001 Q4 | 568.05 Thousand USD | -70.3% |
| 2000 Q3 | 1.73 Million USD | -33.2% |
| 2000 Q2 | 2.6 Million USD | 5.71% |
| 2000 Q1 | 2.45 Million USD | 3.53% |
| 2000 FY | 1.75 Million USD | -26.06% |
| 2000 Q4 | 1.75 Million USD | 1.14% |
| 1999 Q2 | 2 Million USD | 25.0% |
| 1999 FY | 2.37 Million USD | 18.8% |
| 1999 Q3 | 2.1 Million USD | 5.0% |
| 1999 Q4 | 2.37 Million USD | 13.14% |
| 1999 Q1 | 1.6 Million USD | -20.0% |
| 1998 Q3 | 1.6 Million USD | 45.45% |
| 1998 Q2 | 1.1 Million USD | 0.0% |
| 1998 FY | 2 Million USD | -16.67% |
| 1998 Q1 | 1.1 Million USD | -54.17% |
| 1998 Q4 | 2 Million USD | 25.0% |
| 1997 Q3 | 2.6 Million USD | -23.53% |
| 1997 Q2 | 3.4 Million USD | 209.09% |
| 1997 Q1 | 1.1 Million USD | -26.67% |
| 1997 FY | 2.4 Million USD | 60.0% |
| 1997 Q4 | 2.4 Million USD | -7.69% |
| 1996 Q2 | 500 Thousand USD | 400.0% |
| 1996 Q4 | 1.5 Million USD | 15.38% |
| 1996 Q3 | 1.3 Million USD | 160.0% |
| 1996 Q1 | 100 Thousand USD | -93.75% |
| 1996 FY | 1.5 Million USD | -6.25% |
| 1995 Q1 | 2.7 Million USD | -28.95% |
| 1995 FY | 1.6 Million USD | -57.89% |
| 1995 Q4 | 1.6 Million USD | -44.83% |
| 1995 Q3 | 2.9 Million USD | 26.09% |
| 1995 Q2 | 2.3 Million USD | -14.81% |
| 1994 FY | 3.8 Million USD | -9.52% |
| 1994 Q3 | 2.6 Million USD | -44.68% |
| 1994 Q1 | 3.9 Million USD | -7.14% |
| 1994 Q2 | 4.7 Million USD | 20.51% |
| 1994 Q4 | 3.8 Million USD | 46.15% |
| 1993 Q4 | 4.2 Million USD | -30.0% |
| 1993 Q3 | 6 Million USD | -13.04% |
| 1993 FY | 4.2 Million USD | -55.79% |
| 1993 Q1 | 8 Million USD | -15.79% |
| 1993 Q2 | 6.9 Million USD | -13.75% |
| 1992 Q4 | 9.5 Million USD | 28.38% |
| 1992 Q3 | 7.4 Million USD | 3800.0% |
| 1992 FY | 9.5 Million USD | 5.56% |
| 1992 Q1 | 11.3 Million USD | 25.56% |
| 1992 Q2 | -200 Thousand USD | -101.77% |
| 1991 Q3 | 8.5 Million USD | 0.0% |
| 1991 Q4 | 9 Million USD | 5.88% |
| 1991 Q1 | 9.6 Million USD | 74.55% |
| 1991 FY | 9 Million USD | 63.64% |
| 1990 Q2 | 7.4 Million USD | 5.71% |
| 1990 Q3 | 5.6 Million USD | -24.32% |
| 1990 Q4 | 5.5 Million USD | -1.79% |
| 1990 Q1 | 7 Million USD | 140.46% |
| 1990 FY | 5.5 Million USD | 131.79% |
| 1989 FY | -17.3 Million USD | 3.89% |
| 1989 Q4 | -17.3 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 2.58 Million USD | 70.722% |
| AngioDynamics, Inc. | -70.14 Million USD | 101.077% |
| AtriCure, Inc. | -9.81 Million USD | 107.698% |
| Avinger, Inc. | 10.12 Million USD | 92.533% |
| Azenta, Inc. | -618.47 Million USD | 100.122% |
| BioLife Solutions, Inc. | 7.25 Million USD | 89.581% |
| The Cooper Companies, Inc. | 2.44 Billion USD | 99.969% |
| Ekso Bionics Holdings, Inc. | -1.47 Million USD | 151.405% |
| Femasys Inc. | -15.01 Million USD | 105.033% |
| GlucoTrack, Inc. | -4.29 Million USD | 117.59% |
| Harvard Bioscience, Inc. | 38.49 Million USD | 98.037% |
| Hologic, Inc. | 374.4 Million USD | 99.798% |
| ICU Medical, Inc. | 1.45 Billion USD | 99.948% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 100.028% |
| KORU Medical Systems, Inc. | -7.03 Million USD | 110.738% |
| LeMaitre Vascular, Inc. | -5.17 Million USD | 114.605% |
| Innovative Eyewear, Inc. | -4.28 Million USD | 117.625% |
| Innovative Eyewear, Inc. | -4.28 Million USD | 117.625% |
| Masimo Corporation | 804 Million USD | 99.906% |
| Microbot Medical Inc. | -2.28 Million USD | 133.056% |
| Meihua International Medical Technologies Co., Ltd. | -9.59 Million USD | 107.875% |
| Merit Medical Systems, Inc. | 302.22 Million USD | 99.75% |
| Nephros, Inc. | -2.47 Million USD | 130.581% |
| NovoCure Limited | 355.42 Million USD | 99.787% |
| NEXGEL, Inc. | 98 Thousand USD | -671.081% |
| NEXGEL, Inc. | 98 Thousand USD | -671.081% |
| Singular Genomics Systems, Inc. | 59.05 Million USD | 98.72% |
| OraSure Technologies, Inc. | -276.9 Million USD | 100.273% |
| Pro-Dex, Inc. | 10.91 Million USD | 93.078% |
| Pulse Biosciences, Inc. | -35.22 Million USD | 102.145% |
| Predictive Oncology Inc. | -5.87 Million USD | 112.869% |
| Precision Optics Corporation, Inc. | 3.02 Million USD | 75.054% |
| QuidelOrtho Corporation | 2.49 Billion USD | 99.97% |
| Repligen Corporation | -39.51 Million USD | 101.912% |
| Sanara MedTech Inc. | 6.64 Million USD | 88.628% |
| STAAR Surgical Company | -147.2 Million USD | 100.513% |
| Sharps Technology, Inc. | -3.01 Million USD | 125.081% |
| Utah Medical Products, Inc. | -92.52 Million USD | 100.817% |
| DENTSPLY SIRONA Inc. | 1.96 Billion USD | 99.962% |
| Jin Medical International Ltd. | -2.81 Million USD | 126.83% |